Publication | Open Access
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
231
Citations
49
References
2022
Year
UrologyMedicineEnzalutamide VersusPharmacologyRandomized Phase 3PharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseaseOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1